Clinical Implications of New Data on ... - Advanced Prostate...

Advanced Prostate Cancer

21,445 members26,866 posts

Clinical Implications of New Data on Apalutamide + ADT in Castrate-Sensitive Prostate Cancer

snoraste profile image
4 Replies

FYI - one Dr’s opinion on Apalutamide vs Abi.

practiceupdate.com/C/84441/...

Written by
snoraste profile image
snoraste
To view profiles and participate in discussions please or .
Read more about...
4 Replies
LearnAll profile image
LearnAll

Big pharma soldiers are ready to promote a newer ,very expensive " lutamide"….want you to forget Bicalutamide because it is inexpensive.

A few subtle and veiled lies...did you notice that he said " Apalutamide has a new mechanism of action" NO...it does not..who are you trying to fool.. Neeraj. It t's the same old LUTAMIDE...possible more potent but no different in the way it works

Old Wine In New Bottle....An average gullible ,fearful patient will believe your utterings ...Not me.

These are all LUTAMIDES which work by inhibition of AR receptor. Suddenly, AR receptor blockers are COOL...after they badmouthed Bicalutamide and older lutamides for years in order to sell more of 9000 dollar a month Abiraterone

Did you notice veiled criticism of Abiraterone plus Predisone...I was anticipating this as Abi is no more 9000 dollar a month drug.. price is falling. The makers of Zytiga were fighting in court only a few months ago ,to continue patent with ABI plus Predni...but a smart ,bold judge did not allow it...expect more criticism of Abi in next few months as the price dwindles down.

in reply to LearnAll

Enzalutamide is not being used because it makes more money than Bicalutamide. It's being used because it is significantly more effective. One of the problems with Bicalutamide is that it becomes an agonist and feeds the cancer. Here's an article:

healio.com/hematology-oncol...

I agree that "Big Pharma" is price gouging. The prices for these drugs are ridiculous. However, the effectivity of the drugs is a completely separate issue.

snoraste profile image
snoraste

I don’t disagree with you about big pharma’s conflict of interest. But that aside, just objectively evaluating Apalutamide vs Abi on their own merits, the question is if there’s any benefits. Apalutamide supposed to be easier on your brain fog, and fatigue. And you don’t take prednisone with it. If it’s all true, the final question is if it can do at least as “good” of a job as Abi. IF the answer is yes (and there has not been a clinical trial to prove it yet), I don’t see why not switching to Apalutamide if covered by your insurance?

I spoke to my MO and he was kind of ambivalent about it. He did agree that Apalutamide is supposed to be better for brain fog and fatigue though.

LearnAll profile image
LearnAll in reply to snoraste

Yes ...lumatamide family (Bicalutamide, Enzalutamide, Apalutamide etc.) are nbetter in some ways. My point was that its a group effect (all lutamides including Bicalutamide) and its not specific to Apalutamide.

You may also like...

Apalutamide for Metastatic Castration-Sensitive Prostate Cancer

plus placebo.\\" https://www.practiceupdate.com/C/84533/56?elsca1=emc_enews_topic-alert

RT, ADT and Apalutamide for N1, M0,castration sensitive status

Looking for people with experience of RT, ADT and Apalutamide at the same time for N1, M0...

Apalutamide/ADT Confers 100% Recurrence-Free Survival in High-Risk Prostate Cancer

https://www.oncnursingnews.com/view/apalutamide-adt-confers-100-recurrence-free-survival-in-high-ris

Castrate resistant prostate cancer

now spread to the rectum, bladder and I believe on one of his vertebrae. Bicaglutamide no longer...

Prostate cancer and sexual function implications and incontinence.